Results 241 to 250 of about 76,819 (327)

(5) ABNORMAL LIPID METABOLISM IN CLINICAL AND EXPERIMENTAL CHOLESTASIS

, 1980
Yasutoshi Muto, Takashi Ando
openalex   +2 more sources

Liver Involvement in Celiac Disease and Immune‐Mediated Diseases of the Small Bowel

Liver International, Volume 45, Issue 8, August 2025.
ABSTRACT Disorders of the hepatobiliary system are commonly associated with gastrointestinal (GI) diseases. The GI and hepatobiliary systems interact through the portal vein system and enterohepatic circulation, creating a gut–liver axis that allows for a complex multidirectional interplay between immune, hormonal, dietary and environmental luminal ...
Nicoletta Nandi, Elena F. Verdu, Detlef Schuppan, Andres Jose Gomez‐Aldana, Maria Ines Pinto‐Sanchez, Francesco Simone Conforti, Marco Maggioni, Flavio Caprioli, Luca Elli   +8 more
wiley   +1 more source

An integrin-based quercetin 7-rhamnoside liver-targeted delivery liposomes for intrahepatic cholestasis in pregnancy. [PDF]

Mater Today Bio
Feng X, Dai L, Guo Y, Zhong L, Zheng Y, Feng S, Cao L, Yuan Z.   +7 more
europepmc   +1 more source

Problems in Intrahepatic Cholestasis. Second International Symposium on Intrahepatic Cholestasis, Florence 1978

, 1980
Thomas J. Layden
openalex   +1 more source

Odevixibat for Episodic Intrahepatic Cholestasis due to Biallelic Mutations in ATP8B1: A Case Series

Liver International, Volume 45, Issue 8, August 2025.
ABSTRACT Background & Aims In episodic intrahepatic cholestasis (IC; known historically as benign recurrent intrahepatic cholestasis), intermittent cholestasis is typically followed by periods of remission. During cholestatic episodes, symptoms can include jaundice, fatigue, abdominal pain, diarrhoea, and severe pruritus that can interfere with ...
Angelo Di Giorgio, Hans Blokzijl, Emmanuel Gonzalès, Magdalena Salcedo, Wendy L. van der Woerd, Christine Clemson, Lionel Thevathasan, Velichka Valcheva, Barbara Valzasina, Henkjan J. Verkade   +9 more
wiley   +1 more source

Response to "Letter to the Editor in response to: 'ZFYVE19 gene mutation: A novel variant of progressive familial intrahepatic cholestasis'". [PDF]

JPGN Rep
Dalal BS.
europepmc   +1 more source

Physiologic cholestasis

Gastroenterology, 1980
openaire   +2 more sources

Chronic Nanoplastic Exposure Promotes the Development and Progression of Metabolic Dysfunction‐Associated Steatotic Liver Disease

Liver International, Volume 45, Issue 8, August 2025.
ABSTRACT Background and Aims Plastic particles are a global pollution problem, and humans are potentially exposed to them. Ingested plastic particles, microparticles (MPs) and nanoparticles (NPs), predominantly accumulate in the liver and cause hepatotoxicity through oxidative stress and metabolic dysfunction.
Jinsol Han, Hayeong Jeong, Chanbin Lee, Ahyeon Sung, Yung Hyun Choi, Youngmi Jung   +5 more
wiley   +1 more source

De novo CDKN1C variant in Beckwith-Wiedermann spectrum with atypical complications. [PDF]

Hum Genome Var
Moriura Y, Nishio Y, Ichimura S, Noda H, Tanahashi Y, Yamamoto H, Nakazawa Y, Oso T, Sato Y, Takenouchi T, Saitoh S, Muramatsu Y, Ogi T.   +12 more
europepmc   +1 more source

Pharmacokinetics of Digitoxin in Dogs with or without Cholestasis Experimentally Induced by Common Bile Duct Ligation

, 1987
Yoshimichi Miyazawa
openalex   +2 more sources